Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
There’s been plenty of talk re Nasdaq and Mr R’s comments about Al’s letter to the Times makes sense. However, the Avacta Investor Key Information page which was updated on 27th January 2023, says this:
“Avacta Group has not applied or agreed to have any of its securities (including its AIM securities) admitted or traded on any other exchanges or trading platforms.”
Which I guess adds more weight to licence deal(s)?
Bella, thank you for taking the time to explain, much appreciated! Please bear with me though, it still leaves me with a question:
How can the MM fill a 1.6m buy order, ie, sell 1.6m shares to a large buyer during the day, at the same time as selling a large amount of shares to PI’s all day. Where did all these cheap shares suddenly come from to satisfy all this selling to buyers by the MM’s? The volume of shares bought by MM’s today was only a relatively small .75m shares.
Maybe I should be content that I’m no trader, but rather a content, if a little confused LTH!
I’d so love these to be buys! But I’d assumed that the three 0.54m trades were posted to reflect a large sale that’s been going on all day. There’s been a ton of buying today with the SP dropping, and it makes sense to me that the MM had 1.6m shares to sell off? If my thinking is wrong then please put me right!
I thought Avacta had fallen out of the index but an MSCI fact sheet dated Jan 23 reveals the company to be amongst the top ten constituents of the UK Micro Cap list.
https://www.msci.com/documents/10199/b8252f33-2482-4961-afb1-5deae71efe24
If the link doesn’t work just search for Avacta on m s c i . com
Bella, you mentioned the Science Day as being for investors/significant shareholders. Are these your words or has there been an announcement regarding attendees? I had thought the Science day was a closed presentation to analysts and fund managers.
Apart from compiling and making sense of the enormous amount of data to be presented in a way we all understand, AVCT are planning an event which will be attended by city analysts, fund managers and Key Opinion Leaders in the field of oncology. (Press?)
Having experienced the pain and frustration of trying to organise a relatively simple family party, I’m amazed that AVCT can organise such an event by end Feb.
Apart from compiling and making ease of the enormous amount of data to be presented in a way we all understand, AVCT are planning an event which will be attended by city analysts, fund managers and Key Opinion Leaders in the field of oncology. (Press?)
Having experienced the pain and frustration of trying to organise the relatively simple family party, I’m amazed that AVCT can organise such an event by end Feb.
Unless they’re hanging on for potential failure of the trial (as they’re likely driven by statistics) it would make sense for Brontë to have closed today. We’ll find out tomorrow evening when the short report is published. That’d account for 1,330,000 shares scooped up.
Mr R. On days when there’s constant buying and the SP is static or falling, there’s often allegations of MM games or corruption.
But isn’t it more likely that there’s a big seller in the background; I mean, the MM’s have got to be getting a decent supply of shares from somewhere, to be willing to sell them on so cheaply.
It’s frustrating I admit, but as a LTH with an outsize holding, I fix my sights on the end game and don’t worry about the everyday trades.
Both the ‘Total Market Solutions’ article, and the Vox interview with ‘Premier Milton’ released today, make reference to the need for Phase-3 trials! Can anybody reference an official text which specifies that this is NOT the case? Thanks.
Hi LiveData, that’s the second time you’ve posted about Avacta’s interview with Third-Bridge. It sounds really interesting, but my Google searches for TB and Avacta merely point back to your LSE post!
Please would you provide more information.